| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_666e16c6cc140b108e112d0db21b9c30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5837cc3fe9e05283876fe3a7d7edf545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6acd117c4f32c1efc2ebf9f7bacb79cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5033381fa95562fdcf40107fc84ade41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_451ef763db97bd475ef182daf70cd917
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6824993d583369eddf6d6ed8dae08d32 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2007-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0ad083beaa238b0707c47869f8bda83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13dd9b2b0ffc3cb5716bcdf42cba50e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea91f69ecd74132956fbd9fc639f2540
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a0e1a5761ab2bdd4ab68935b2240f2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_debd24e892e08b51ba2e81f92382b079
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ce33fd059840cae26b95d7aeace4f29 |
| publicationDate |
2010-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010003670-A1 |
| titleOfInvention |
Characterizing prostate cancer |
| abstract |
Methods and kits for predicting the course or aggressiveness of prostate cancer include detecting the methylation status of various genes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009186360-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014315192-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11085088-B2 |
| priorityDate |
2006-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |